Personalized medicine for lung cancer

被引：1

作者：

Fong, Kwun M. ^{[1
]}

Yang, Ian A. ^{[1
]}

Bowman, Rayleen V. ^{[1
]}

机构：

[1] Univ Queensland, Prince Charles Hosp, Thorac Res Ctr, Dept Thorac Med, Brisbane, Qld, Australia

来源：

LUNG CANCER MANAGEMENT | 2012年 / 1卷 / 02期

基金：

澳大利亚国家健康与医学研究理事会;

关键词：

D O I：

10.2217/LMT.12.22

中图分类号：

R56 [呼吸系及胸部疾病];

学科分类号：

摘要：

引用

页码：83 / 86

页数：4

共 19 条

[1] ROS1 Rearrangements Define a Unique Molecular Class of Lung Cancers [J].

Bergethon, Kristin ;

Shaw, Alice T. ;

Ou, Sai-Hong Ignatius ;

Katayama, Ryohei ;

Lovly, Christine M. ;

McDonald, Nerina T. ;

Massion, Pierre P. ;

Siwak-Tapp, Christina ;

Gonzalez, Adriana ;

Fang, Rong ;

Mark, Eugene J. ;

Batten, Julie M. ;

Chen, Haiquan ;

Wilner, Keith D. ;

Kwak, Eunice L. ;

Clark, Jeffrey W. ;

Carbone, David P. ;

Ji, Hongbin ;

Engelman, Jeffrey A. ;

Mino-Kenudson, Mari ;

Pao, William ;

Iafrate, A. John .

JOURNAL OF CLINICAL ONCOLOGY, 2012, 30 (08) :863-870

[2] Quantitative Analysis of Tumor in Bronchial Biopsy Specimens [J].

Coghlin, Caroline L. ;

Smith, Louise J. ;

Bakar, Salmah ;

Stewart, Keith N. ;

Devereux, Graham S. ;

Nicolson, Marianne C. ;

Kerr, Keith M. .

JOURNAL OF THORACIC ONCOLOGY, 2010, 5 (04) :448-452

[3]

Committee on a Framework for Developing a New Taxonomy of Disease, 2011, TOW PREC MED BUILD K

[4] Resistance to Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitors in Non-Small Cell Lung Cancer [J].

Hammerman, Peter S. ;

Jaenne, Pasi A. ;

Johnson, Bruce E. .

CLINICAL CANCER RESEARCH, 2009, 15 (24) :7502-7509

[5] Personalized cancer medicine-advances and socio-economic challenges [J].

Jackson, David B. ;

Sood, Anil K. .

NATURE REVIEWS CLINICAL ONCOLOGY, 2011, 8 (12) :735-741

[6] Randomized phase II trial comparing bevacizumab plus carboplatin and paclitaxel with carboplatin and paclitaxel alone in previously untreated locally advanced or metastatic non-small-cell lung cancer [J].

Johnson, DH ;

Fehrenbacher, L ;

Novotny, WF ;

Herbst, RS ;

Nemunaitis, JJ ;

Jablons, DM ;

Langer, CJ ;

DeVore, RF ;

Gaudreault, J ;

Damico, LA ;

Holmgren, E ;

Kabbinavar, F .

JOURNAL OF CLINICAL ONCOLOGY, 2004, 22 (11) :2184-2191

[7] Personalized medicine for lung cancer: new challenges for pathology [J].

Kerr, Keith M. .

HISTOPATHOLOGY, 2012, 60 (04) :531-546

[8] Anaplastic Lymphoma Kinase Inhibition in Non-Small-Cell Lung Cancer [J].

Kwak, Eunice L. ;

Bang, Yung-Jue ;

Camidge, D. Ross ;

Shaw, Alice T. ;

Solomon, Benjamin ;

Maki, Robert G. ;

Ou, Sai-Hong I. ;

Dezube, Bruce J. ;

Jaenne, Pasi A. ;

Costa, Daniel B. ;

Varella-Garcia, Marileila ;

Kim, Woo-Ho ;

Lynch, Thomas J. ;

Fidias, Panos ;

Stubbs, Hannah ;

Engelman, Jeffrey A. ;

Sequist, Lecia V. ;

Tan, WeiWei ;

Gandhi, Leena ;

Mino-Kenudson, Mari ;

Wei, Greg C. ;

Shreeve, S. Martin ;

Ratain, Mark J. ;

Settleman, Jeffrey ;

Christensen, James G. ;

Haber, Daniel A. ;

Wilner, Keith ;

Salgia, Ravi ;

Shapiro, Geoffrey I. ;

Clark, Jeffrey W. ;

Iafrate, A. John .

NEW ENGLAND JOURNAL OF MEDICINE, 2010, 363 (18) :1693-1703

[9] Assessment of cumulative evidence for the association between glutathione S-transferase polymorphisms and lung cancer: application of the Venice interim guidelines [J].

Langevin, Scott M. ;

Ioannidis, John P. A. ;

Vineis, Paolo ;

Taioli, Emanuela .

PHARMACOGENETICS AND GENOMICS, 2010, 20 (10) :586-597

[10] Preparing for Precision Medicine [J].

Mirnezami, Reza ;

Nicholson, Jeremy ;

Darzi, Ara .

NEW ENGLAND JOURNAL OF MEDICINE, 2012, 366 (06) :489-491

← 1 2 →